Cat.#: ACPP-1275
| Despition | Usherin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg | inquiry |
| ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1410 | Human MEOX2 Protein (AC1410) | 2 µg | inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1793 | Human HSPB8 Protein, His (AC1793) | 2 µg | inquiry |
| ACPP-1813 | Human HAAO Protein (AC1813) | 5 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
| ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.